Americans have long construed drugs of abuse as choices. Poor choices that can cost users their lives, to be sure, but choices nonetheless. But what if drugs of
London 25 September 2018 — Today, GSK and Aeras reported that GSK’s M72/AS01E[1] candidate vaccine significantly reduced the incidence of pulmonary tuberculosis disease in HIV-negative adults with latent
The medical community has long known that patients on long-term opioid therapy often have significantly more health care visits. But adhering to a standardized care process model for
More than 1,000 Canadians died of an apparent opioid overdose in the first three months of this year, bringing the toll since the public health crisis erupted in
Pharmaceutical giant AbbVie illegally plied doctors with cash, gifts and services to prescribe one of the world’s best-selling drugs, Humira, despite its potentially deadly complications, a California official
September 14, 2018 — Today, the US Food and Drug Administration (FDA) approved Ajovy (fremanezumab-vfrm) for the preventive treatment of migraine in adults. Ajovy is the second FDA-approved
(HealthDay)—With millions of pain-plagued Americans looking for an alternative to opioids, the solution for some might be no medicine at all. New research suggests that a good many
Although no prevention method will guarantee you won’t get sick, getting a flu vaccine is the best way to protect yourself and your loved ones from the nasty
(HealthDay)—As the U.S. opioid addiction epidemic widened, the federal Drug Enforcement Agency (DEA) placed the prescription painkillers in a tougher-to-refill category. Many states also mandated monitoring programs to
PRINCETON, N.J.–(BUSINESS WIRE)–August 17, 2018 — Bristol-Myers Squibb Company (NYSE:BMY) today announced that Opdivo (nivolumab) received approval from the U.S. Food and Drug Administration (FDA) as the first
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
